|
Genzyme’s Ireland Plant Expansion Gets FDA, EMA Approval as Company Regains Footing
U.S. and EU regulators have approved a $150 million expansion of Genzyme’s Waterford, Ireland, plant, boosting the drugmaker’s capacity as it works to rebound from manufacturing troubles.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives